Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 21 studies | 31% ± 20% | |
| goblet cell | 5 studies | 35% ± 12% | |
| endothelial cell of lymphatic vessel | 4 studies | 39% ± 33% | |
| connective tissue cell | 3 studies | 21% ± 1% | |
| chondrocyte | 3 studies | 71% ± 23% | |
| smooth muscle cell | 3 studies | 48% ± 33% |
Insufficient scRNA-seq data for expression of FMOD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 98% | 7695.27 | 241 / 245 | 97% | 308.65 | 489 / 502 |
| ovary | 100% | 19128.09 | 180 / 180 | 93% | 127.78 | 398 / 430 |
| breast | 100% | 9583.44 | 457 / 459 | 91% | 176.62 | 1016 / 1118 |
| thymus | 100% | 10624.56 | 652 / 653 | 89% | 98.95 | 541 / 605 |
| lung | 100% | 9585.38 | 577 / 578 | 88% | 82.32 | 1022 / 1155 |
| stomach | 100% | 9834.54 | 358 / 359 | 88% | 101.53 | 251 / 286 |
| intestine | 86% | 4493.64 | 827 / 966 | 85% | 87.61 | 449 / 527 |
| bladder | 95% | 5696.71 | 20 / 21 | 60% | 47.17 | 304 / 504 |
| uterus | 99% | 14512.88 | 169 / 170 | 52% | 76.69 | 239 / 459 |
| esophagus | 69% | 3256.50 | 1004 / 1445 | 69% | 55.64 | 127 / 183 |
| skin | 74% | 4381.24 | 1330 / 1809 | 47% | 106.80 | 220 / 472 |
| pancreas | 16% | 473.01 | 51 / 328 | 93% | 127.96 | 166 / 178 |
| blood vessel | 100% | 46749.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 10781.53 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 79% | 60.06 | 63 / 80 |
| kidney | 36% | 1771.39 | 32 / 89 | 41% | 28.53 | 370 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 51.05 | 33 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 40.78 | 20 / 29 |
| heart | 66% | 9582.04 | 565 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 43% | 1481.80 | 112 / 258 | 14% | 5.83 | 32 / 230 |
| spleen | 54% | 1944.15 | 129 / 241 | 0% | 0 | 0 / 0 |
| brain | 1% | 22.76 | 16 / 2642 | 29% | 51.25 | 202 / 705 |
| liver | 4% | 159.80 | 10 / 226 | 21% | 16.23 | 86 / 406 |
| muscle | 11% | 620.84 | 89 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_0007181 | Biological process | transforming growth factor beta receptor complex assembly |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0005615 | Cellular component | extracellular space |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0030021 | Molecular function | extracellular matrix structural constituent conferring compression resistance |
| Gene name | FMOD |
| Protein name | Fibromodulin Fibromodulin (FM) (Collagen-binding 59 kDa protein) (Keratan sulfate proteoglycan fibromodulin) (KSPG fibromodulin) |
| Synonyms | SLRR2E FM |
| Description | FUNCTION: Affects the rate of fibrils formation. May have a primary role in collagen fibrillogenesis (By similarity). . FUNCTION: Affects the rate of fibrils formation. May have a primary role in collagen fibrillogenesis. . |
| Accessions | Q06828 ENST00000354955.5 A0A3B3IRN5 ENST00000647586.1 |
